Similarly, Zhao et al. showed that STC2 ameliorated hepatosteatosis and hypertriglyceridemia in obese mice through the activation of Signal transducer and activator of transcription 3 (STAT3) signaling pathway (10). The gene discussed is STAT3; the disease is hypertriglyceridemia.